Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CASR | P41180 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13892802 | 0.88 | NPC1 (0.36) | KDM4ENPC1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL13196161 | 0.79 | MEN1 (0.31) | — | |
| SCHEMBL12348738 | 0.79 | RAB9A (0.34) | KDM4ENPC1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL12657704 | 0.77 | — | — | |
| SCHEMBL14435170 | 0.76 | NPC1 (0.39) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL22245948 | 0.75 | RAB9A (0.36) | KDM4ENPC1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL14327672 | 0.74 | — | — | |
| SCHEMBL13553389 | 0.73 | KIF11 (0.37) | KDM4ENPC1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL20623235 | 0.72 | NPC1 (0.33) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL13564613 | 0.71 | RORC (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9453103-B2 | Method for producing aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-09-27 | — | — | US | disclosed |
| US-20150322199-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322199-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | PAH, DDC, DDT | KDM4E 2639/4885NPC1 2375/4885HPGD 2973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.